Efficacy and safety of the paul glaucoma implant in the treatment of refractory primary congenital glaucoma.

The PGI appears to be a safe and effective option for managing refractory primary congenital glaucoma, demonstrating significant IOP reduction and decreased dependence on glaucoma medications over a one-year period, with a high success rate and manageable complication profile.